294 related articles for article (PubMed ID: 28502032)
1. Circulating markers of bone turnover.
Vervloet MG; Brandenburg VM;
J Nephrol; 2017 Oct; 30(5):663-670. PubMed ID: 28502032
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
[No Abstract] [Full Text] [Related]
3. News on biomarkers in CKD-MBD.
Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
[TBL] [Abstract][Full Text] [Related]
4. Biological markers in the diagnosis of the different forms of renal osteodystrophy.
Ferreira A; Drüeke TB
Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481
[TBL] [Abstract][Full Text] [Related]
5. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
[TBL] [Abstract][Full Text] [Related]
6. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
[TBL] [Abstract][Full Text] [Related]
7. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
9. Bone markers during acute burn care: Relevance to clinical practice?
Rousseau AF; Damas P; Delanaye P; Cavalier E
Burns; 2017 Feb; 43(1):176-181. PubMed ID: 27576929
[TBL] [Abstract][Full Text] [Related]
10. A new approach for evaluating bone turnover in chronic kidney disease.
Tolouian R; Hernandez GT; Chiang WY; Gupta A
Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
[TBL] [Abstract][Full Text] [Related]
11. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
Liangos O; Kirchhoff S; Buchholz J; Ketteler M
Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
[TBL] [Abstract][Full Text] [Related]
12. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fracture risk in chronic kidney disease.
Torres PAU; Cohen-Solal M
J Nephrol; 2017 Oct; 30(5):653-661. PubMed ID: 28386879
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
[TBL] [Abstract][Full Text] [Related]
17. The importance of bone biomarkers in the diagnosis of renal osteodystrophy.
Pena YT; Soyibo AK; McGrowder D; Clarke TR; Barton EN
West Indian Med J; 2010 Jun; 59(3):332-7. PubMed ID: 21291118
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
19. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
20. Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.
Massy Z; Drueke T
J Nephrol; 2017 Oct; 30(5):629-634. PubMed ID: 28405928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
